Zhouguang Hui (Hui Zhouguang)

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 30

Top Topics

Locally Advanced

Radiation Therapy

Small Cell Lung Cancer

Squamous Cell Carcinoma

Top Venues

Thoracic cancer

Disease markers

Oxidative medicine and cellular longevity

This page only lists publications with an associated author ORCID identifier.

Publications

Zeliang Ma, Bin Liang, Ran Wei, Yunsong Liu, Yongxing Bao, Meng Yuan, Yu Men, Jianyang Wang, Lei Deng, Yirui Zhai, Nan Bi, Luhua Wang, Jianrong Dai, Zhouguang Hui
Enhanced prediction of postoperative radiotherapy-induced esophagitis in non-small cell lung cancer: Dosiomic model development in a real-world cohort and validation in the PORT-C randomized controlled trial. Thoracic cancer (2023)
Yajing Wu, Vivek Verma, Carl M Gay, Yujia Chen, Fei Liang, Qiang Lin, Jianing Wang, Wei Zhang, Zhouguang Hui, Min Zhao, Jun Wang, Joe Y Chang
Neoadjuvant immunotherapy for advanced, resectable non-small cell lung cancer: A systematic review and meta-analysis. Cancer (2023)
Meng Yuan, Yirui Zhai, Yu Men, Maoyuan Zhao, Xin Sun, Zeliang Ma, Yongxing Bao, Xu Yang, Shuang Sun, Yunsong Liu, Wanting Zhang, Zhouguang Hui
Anlotinib Enhances the Antitumor Activity of High-Dose Irradiation Combined with Anti-PD-L1 by Potentiating the Tumor Immune Microenvironment in Murine Lung Cancer. Oxidative medicine and cellular longevity 2022 (2022)
Weiming Han, Xiao Chang, Wencheng Zhang, Jingsong Yang, Shufei Yu, Wei Deng, Wenjie Ni, Zongmei Zhou, Dongfu Chen, Qin-Fu Feng, Jun Liang, Zhouguang Hui, Lvhua Wang, Shugeng Gao, Yu Lin, Xiaohui Chen, Junqiang Chen, Zefen Xiao
Effect of Adjuvant Radiation Dose on Survival in Patients with Esophageal Squamous Cell Carcinoma. Cancers 14 (23) (2022)
Linlin Xiao, Qiang Lin, Mengzhu Hu, Yi Wang, Zhouguang Hui, Fengpeng Wu, Jianing Wang
Could intracranial tumor volume predict prognosis of patients with brain metastases from esophageal carcinoma? Thoracic cancer 13 (8) (2022)
Weiming Han, Xiao Chang, Wencheng Zhang, Jingsong Yang, Shufei Yu, Wei Deng, Wenjie Ni, Zongmei Zhou, Dongfu Chen, Qin-Fu Feng, Jun Liang, Zhouguang Hui, Lvhua Wang, Shugeng Gao, Yu Lin, Xiaohui Chen, Junqiang Chen, Zefen Xiao
Effect of Adjuvant Radiation Dose on Survival in Patients with Esophageal Squamous Cell Carcinoma. Cancers 14 (23) (2022)
Yirui Zhai, Qiang Zeng, Nan Bi, Zongmei Zhou, Zefen Xiao, Zhouguang Hui, Dongfu Chen, Luhua Wang, Jianyang Wang, Wenyang Liu, Lei Deng, Jima Lv, Wenqing Wang, Yang Luo, Junling Li, Xin Wang, Tao Zhang, Yushun Gao, Qinfu Feng
A Single Center Analysis of Thymic Neuroendocrine Tumors. Cancers 14 (19) (2022)
Weiming Han, Xiao Chang, Wencheng Zhang, Jingsong Yang, Shufei Yu, Wei Deng, Wenjie Ni, Zongmei Zhou, Dongfu Chen, Qin-Fu Feng, Jun Liang, Zhouguang Hui, Lvhua Wang, Shugeng Gao, Yu Lin, Xiaohui Chen, Junqiang Chen, Zefen Xiao
Effect of Adjuvant Radiation Dose on Survival in Patients with Esophageal Squamous Cell Carcinoma. Cancers 14 (23) (2022)
Bo Lyu, Yutian Yin, Yilin Zhao, Xu Yang, Jie Gong, Mai Zhang, Guangjin Chai, Zhaohui Li, Mei Shi, Zhouguang Hui, Lina Zhao
Long-Term Clinical Outcomes and Safety Analysis of Superficial Esophageal Cancer Patients Treated with Definitive or Adjuvant Radiotherapy. Cancers 14 (14) (2022)
Jianing Wang, Zhouguang Hui, Qingsong Pang
Is adjuvant immunotherapy a new standard for non-pathological complete response patients with resectable esophageal squamous cell carcinoma? Thoracic cancer 13 (21) (2022)
Linfang Wu, Shijun Zhao, Hui Huang, Wenqing Wang, Tao Zhang, Zongmei Zhou, Qin-Fu Feng, Jun Liang, Zefen Xiao, Zhouguang Hui, Jima Lv, Nan Bi, Luhua Wang
Treatment outcomes of patients with stage III non-small cell lung cancer and interstitial lung diseases receiving intensity-modulated radiation therapy: A single-center experience of 85 cases. Thoracic cancer 13 (11) (2022)
Yongxing Bao, Yang Wang, Zhouguang Hui
Reply: Bayesian analysis supports the role of neoadjuvant chemoradiation followed by surgery for resectable locoregional esophageal cancer. Thoracic cancer 13 (21) (2022)
Meng Yuan, Yirui Zhai, Yu Men, Maoyuan Zhao, Xin Sun, Zeliang Ma, Xu Yang, Shuang Sun, Yongxing Bao, Yunsong Liu, Zhouguang Hui
Famitinib enhances the antitumor effect of radioimmunotherapy in murine lung cancer. Thoracic cancer 13 (23) (2022)
Yongxing Bao, Zeliang Ma, Meng Yuan, Yang Wang, Yu Men, Zhouguang Hui
Comparison of different neoadjuvant treatments for resectable locoregional esophageal cancer: A systematic review and network meta-analysis. Thoracic cancer 13 (17) (2022)
Weiming Han, Xiao Chang, Wencheng Zhang, Jingsong Yang, Shufei Yu, Wei Deng, Wenjie Ni, Zongmei Zhou, Dongfu Chen, Qin-Fu Feng, Jun Liang, Zhouguang Hui, Lvhua Wang, Shugeng Gao, Yu Lin, Xiaohui Chen, Junqiang Chen, Zefen Xiao
Effect of Adjuvant Radiation Dose on Survival in Patients with Esophageal Squamous Cell Carcinoma. Cancers 14 (23) (2022)
Xin Sun, Yu Men, Jianyang Wang, Yongxing Bao, Xu Yang, Maoyuan Zhao, Shuang Sun, Meng Yuan, Zeliang Ma, Zhouguang Hui
Risk of cardiac-related mortality in stage IIIA-N2 non-small cell lung cancer: Analysis of the Surveillance, Epidemiology, and End Results (SEER) database. Thoracic cancer 12 (9) (2021)
Yufan Yang, Tao Zhang, Zongmei Zhou, Jun Liang, Dongfu Chen, Qin-Fu Feng, Zefen Xiao, Zhouguang Hui, Jima Lv, Lei Deng, Xin Wang, Wenqing Wang, Jianyang Wang, Wenyang Liu, Yirui Zhai, Jie Wang, Nan Bi, Luhua Wang
Development and validation of a prediction model using molecular marker for long-term survival in unresectable stage III non-small cell lung cancer treated with chemoradiotherapy. Thoracic cancer 13 (3) (2021)
Kunpeng Xu, Jun Liang, Tao Zhang, Zongmei Zhou, Dongfu Chen, Qin-Fu Feng, Zefen Xiao, Zhouguang Hui, Jima Lu, Xin Wang, Lei Deng, Wenyang Liu, Jianyang Wang, Yirui Zhai, Jie Wang, Nan Bi, Luhua Wang
Clinical outcomes and radiation pneumonitis after concurrent EGFR-tyrosine kinase inhibitors and radiotherapy for unresectable stage III non-small cell lung cancer. Thoracic cancer 12 (6) (2021)
Yongxing Bao, Xu Yang, Yu Men, Jingjing Kang, Xin Sun, Maoyuan Zhao, Shuang Sun, Meng Yuan, Zeliang Ma, Zhouguang Hui
Postoperative radiotherapy improves survival of patients with ypN2 non-small cell lung cancer after neoadjuvant chemotherapy followed by surgery - A propensity score matching study of the Surveillance, Epidemiology, and End Results database. Thoracic cancer 13 (3) (2021)
Yujuan Zhang, Yu Men, Jianyang Wang, Puyuan Xing, Jun Zhao, Junling Li, Danfei Xu, Zhouguang Hui, Wei Cui
Epithelial circulating tumor cells with a heterogeneous phenotype are associated with metastasis in NSCLC. Journal of cancer research and clinical oncology (2021)
Meng Yuan, Yirui Zhai, Yu Men, Jianyang Wang, Lei Deng, Wenqing Wang, Yongxing Bao, Xu Yang, Shuang Sun, Zeliang Ma, Yunsong Liu, Jianing Wang, Hui Zhu, Zhouguang Hui
Endostar (rh-endostatin) improves efficacy of concurrent chemoradiotherapy for locally advanced non-small cell lung cancer: A systematic review and meta-analysis. Thoracic cancer 12 (23) (2021)
Mengchun Gong, Shuang Wang, Lezi Wang, Chao Liu, Jianyang Wang, Qiang Guo, Hao Zheng, Kang Xie, Chenghong Wang, Zhouguang Hui
Evaluation of Privacy Risks of Patients' Data in China: Case Study. JMIR medical informatics 8 (2) (2020)
Maoyuan Zhao, Jingsong Wang, Meng Yuan, Zeliang Ma, Yongxin Bao, Zhouguang Hui
Multivariate gene expression-based survival predictor model in esophageal adenocarcinoma. Thoracic cancer 11 (10) (2020)
Meng Yuan, Yu Men, Jingjing Kang, Xin Sun, Maoyuan Zhao, Yongxing Bao, Xu Yang, Shuang Sun, Zeliang Ma, Jianyang Wang, Lei Deng, Wenqing Wang, Yirui Zhai, Wenyang Liu, Tao Zhang, Xin Wang, Nan Bi, Jima Lv, Jun Liang, Qinfu Feng, Dongfu Chen, Zefen Xiao, Zongmei Zhou, Luhua Wang, Zhouguang Hui
Postoperative radiotherapy for pathological stage IIIA-N2 non-small cell lung cancer with positive surgical margins. Thoracic cancer 12 (2) (2020)
Maoyuan Zhao, Ting Wang, Zhouguang Hui
Aspirin overcomes cisplatin resistance in lung cancer by inhibiting cancer cell stemness. Thoracic cancer 11 (11) (2020)
Yirui Zhai, Zhouguang Hui, Yu Men, Yang Luo, Yushun Gao, Jingjing Kang, Xin Sun, Jianyang Wang
Combined neat model for the prognosis of postoperative stage III-N2 non-small cell lung cancer. Thoracic cancer 11 (9) (2020)
Ma Honglian, Zhouguang Hui, Peng Fang, Zhao Lujun, Li Dongming, Xu Yujin, Bao Yong, Xu Liming, Zhai Yirui, Hu Xiao, Wang Jin, Kong Yue, Wang Lvhua, Chen Ming
Different administration routes of recombinant human endostatin combined with concurrent chemoradiotherapy might lead to different efficacy and safety profile in unresectable stage III non-small cell lung cancer: Updated follow-up results from two phase II trials. Thoracic cancer 11 (4) (2020)
Jingjing Kang, Yang Luo, Di Wang, Yu Men, Jianyang Wang, Yi-Qun Che, Zhouguang Hui
Tumor Mutation Load: A Novel Independent Prognostic Factor in Stage IIIA-N2 Non-Small-Cell Lung Cancer. Disease markers 2019 (2019)
Wenhui Wang, Yu Men, Jianyang Wang, Zongmei Zhou, Dongfu Chen, Zefen Xiao, Qinfu Feng, Jima Lv, Jun Liang, Nan Bi, Shugeng Gao, Luhua Wang, Zhouguang Hui
Postoperative radiotherapy is effective in improving survival of patients with stage pIII-N2 non-small-cell lung Cancer after pneumonectomy. BMC cancer 19 (1) (2019)
Wei Jiang, Wenjue Zhang, Lihong Wu, Lipin Liu, Yu Men, Jingbo Wang, Jun Liang, Zhouguang Hui, Zongmei Zhou, Nan Bi, Luhua Wang
MicroRNA-Related Polymorphisms in PI3K/Akt/mTOR Pathway Genes Are Predictive of Limited-Disease Small Cell Lung Cancer Treatment Outcomes. BioMed research international 2017 (2017)